Former Secretary of State Mike Pompeo criticizes President Biden’s prescription drug price plan, arguing it will only benefit the government and Big Pharma while raising costs for families. He specifically targets the Federal Trade Commission’s (FTC) proposed regulations on pharmacy benefit managers (PBMs), arguing they will harm patients by increasing drug prices and weakening the free market.